LncRNA-Disease Association Prediction Using Two-Side Sparse Self-Representation
暂无分享,去创建一个
Yiwen Sun | Zexuan Zhu | Le Ou-Yang | Xiao-Fei Zhang | Yan-Ran Li | Shan He | Jiang Huang | Zexuan Zhu | Shan He | Yiwen Sun | Le Ou-Yang | Xiao-Fei Zhang | Jiang Huang | Yan-Ran Li | Ou-Yang Le
[1] Deeksha Bhartiya,et al. Conceptual approaches for lncRNA drug discovery and future strategies , 2012, Expert opinion on drug discovery.
[2] Bin Xu,et al. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22 , 2016, Oncotarget.
[3] Yoshua Bengio,et al. Random Search for Hyper-Parameter Optimization , 2012, J. Mach. Learn. Res..
[4] J. Yuan,et al. Induction effect of MicroRNA-449a on glioma cell proliferation and inhibition on glioma cell apoptosis by promoting PKCα. , 2015, European review for medical and pharmacological sciences.
[5] Nicholas T. Ingolia,et al. Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins , 2013, Cell.
[6] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[7] Chee Keong Kwoh,et al. Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..
[8] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[9] M. Symons,et al. Signaling determinants of glioma cell invasion. , 2013, Advances in experimental medicine and biology.
[10] Hao Ding,et al. Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.
[11] Erkki Oja,et al. Unified Development of Multiplicative Algorithms for Linear and Quadratic Nonnegative Matrix Factorization , 2011, IEEE Transactions on Neural Networks.
[12] Qionghai Dai,et al. Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity , 2015, Scientific Reports.
[13] Xing Chen,et al. PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..
[14] Jiancheng Luo,et al. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications , 2014, Scientific Reports.
[15] Yi Pan,et al. Prediction of lncRNA–disease associations based on inductive matrix completion , 2018, Bioinform..
[16] L. Lanfrancone,et al. Molecular networks in melanoma invasion and metastasis. , 2013, Future oncology.
[17] Xing Chen,et al. FMLNCSIM: fuzzy measure-based lncRNA functional similarity calculation model , 2016, Oncotarget.
[18] O. Gallego,et al. Nonsurgical treatment of recurrent glioblastoma. , 2015, Current oncology.
[19] W. Isaacs,et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.
[20] Xiaobo Zhou,et al. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.
[21] Y. Wang,et al. Mammalian ncRNA-disease repository: a global view of ncRNA-mediated disease network , 2013, Cell Death and Disease.
[22] Lei Zhao,et al. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma , 2017, International journal of molecular medicine.
[23] R. Barnard. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.
[24] J. Mattick,et al. Long Noncoding RNAs in Cardiac Development and Pathophysiology , 2012, Circulation research.
[25] R. Jenkins,et al. Genetics of adult glioma. , 2012, Cancer genetics.
[26] Yu Zhou,et al. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway , 2018, Journal of cellular biochemistry.
[27] Yu Cheng,et al. lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients , 2017, Oncotarget.
[28] David G. Knowles,et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.
[29] Steven D. Brown,et al. ICRM-2011 international chemometrics research meeting , 2012 .
[30] Martin Klein,et al. Psychiatric symptoms in glioma patients: from diagnosis to management , 2015, Neuropsychiatric disease and treatment.
[31] Xuegong Zhang,et al. Computational prediction of associations between long non-coding RNAs and proteins , 2013, BMC Genomics.
[32] Tao Jiang,et al. HOTAIR is a therapeutic target in glioblastoma , 2015, Oncotarget.
[33] Howard Y. Chang,et al. Long noncoding RNAs and human disease. , 2011, Trends in cell biology.
[34] Nina Kočevar,et al. Glioma and glioblastoma - how much do we (not) know? , 2013, Molecular and clinical oncology.
[35] David Zhang,et al. A Survey of Sparse Representation: Algorithms and Applications , 2015, IEEE Access.
[36] Z. Xuan,et al. Long Non-Coding RNAs and Complex Human Diseases , 2013, International journal of molecular sciences.
[37] Zhu-Hong You,et al. PRMDA: personalized recommendation-based MiRNA-disease association prediction , 2017, Oncotarget.
[38] Erkki Oja,et al. Clustering by Low-Rank Doubly Stochastic Matrix Decomposition , 2012, ICML.
[39] Lei Wang,et al. A Novel Method for LncRNA-Disease Association Prediction Based on an lncRNA-Disease Association Network , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[40] Jing Quan,et al. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis. , 2018, Gene.
[41] Dong Wang,et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..
[42] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[43] G. Su,et al. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma , 2015, Tumor Biology.
[44] Xing Chen,et al. LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..
[45] Lei Wang,et al. A Novel Probability Model for LncRNA–Disease Association Prediction Based on the Naïve Bayesian Classifier , 2018, Genes.
[46] J. Liu,et al. Effect of downregulated lncRNA NBAT1 on the biological behavior of glioblastoma cells. , 2018, European Review for Medical and Pharmacological Sciences.
[47] Xing Chen,et al. Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..
[48] S. Leenstra,et al. Recent advances in the molecular understanding of glioblastoma , 2009 .
[49] Xing Chen,et al. Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..
[50] Peng Wang,et al. Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers , 2015, Nucleic Acids Res..
[51] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[52] Svetlana A. Shabalina,et al. Negative Correlation between Expression Level and Evolutionary Rate of Long Intergenic Noncoding RNAs , 2011, Genome biology and evolution.
[53] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[54] J. Mattick,et al. Non‐coding RNAs: regulators of disease , 2010, The Journal of pathology.
[55] Dapeng Hao,et al. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. , 2015, Molecular bioSystems.
[56] M. Gerstenblith,et al. Ultraviolet radiation and melanoma. , 2011, Seminars in cutaneous medicine and surgery.